Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron
- PMID: 2983071
Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron
Abstract
Analogs of quinolinic acid were tested for excitatory properties in evoking neurotransmitter release from striatal cholinergic interneurons and for their ability to lesion these same neurons in vivo (excitotoxin activity). The ability of these analogs to inhibit the specific binding of several ligands thought to label excitatory amino acid receptors was also investigated. Dipicolinic acid (2,6-pyridine dicarboxylic acid) was found to be as potent and as efficacious as quinolinic acid (2,3-pyridine dicarboxylic acid) at N-methyl-D-aspartate (NMDA)-type receptors mediating [3H]acetylcholine release from striatal slices. However, unlike quinolinate, the structure of NMDA is not superimposable upon that of dipicolinic acid. Moreover, unlike quinolinic acid, dipicolinic acid injected intrastriatally did not produce detectable excitotoxic lesions. Most unexpectedly, phthalic acid (1,2-benzene dicarboxylic acid), which lacks a nitrogen, also evoked [3H]acetylcholine release from striatal slices, apparently by acting at NMDA-type receptors. Phthalic acid was equipotent to quinolinic acid and dipicolinic acid but possessed less intrinsic activity than these compounds in evoking [3H]acetylcholine release. Despite its lack of a nitrogen and low intrinsic activity, intrastriatal injection of phthalic acid produced axon-sparing lesions of intrinsic cell bodies, like quinolinic acid as assessed by neurochemical and histologic methods. Quinolinic acid, dipicolinic acid and phthalic acid were moderately potent inhibitors (Kl = approximately equal to 100 microM) of the specific binding of 2-[3H]amino-7-phosphonoheptanoic acid a compound thought to be a competitive antagonist of NMDA-type receptors. In contrast, these three compounds failed to inhibit the chloride-dependent or chloride-independent binding of L-[3H]glutamate or [3H]kainic acid. The present results suggest a major dissociation between the structure-activity relationships for "excitotoxicity" vis-à-vis excitation as reflected in the [3H]acetylcholine release model, for compounds acting at NMDA-type receptors.
Similar articles
-
Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.Synapse. 1989;3(1):38-47. doi: 10.1002/syn.890030106. Synapse. 1989. PMID: 2563916
-
Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.J Pharmacol Exp Ther. 1986 Sep;238(3):938-46. J Pharmacol Exp Ther. 1986. PMID: 2875174
-
Quinolinic acid evokes [3H]acetylcholine release in striatal slices: mediation by NMDA-type excitatory amino acid receptors.Eur J Pharmacol. 1983 Dec 9;96(1-2):111-5. doi: 10.1016/0014-2999(83)90536-8. Eur J Pharmacol. 1983. PMID: 6141057
-
[The receptors involved in the excitatory effects of kynurenines].Farmakol Toksikol. 1989 Jan-Feb;52(1):98-104. Farmakol Toksikol. 1989. PMID: 2540028 Review. Russian.
-
The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.Can J Physiol Pharmacol. 1994 Dec;72(12):1473-82. doi: 10.1139/y94-213. Can J Physiol Pharmacol. 1994. PMID: 7736338 Review.
Cited by
-
Glycine-evoked release of [3H]acetylcholine from rat striatal slices is independent of the NMDA receptor.Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):552-5. doi: 10.1007/BF00182730. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2842697
-
Interactions between topically applied excitatory amino acids on rat cerebral cortex: discrimination by pentobarbitone.Exp Brain Res. 1987;68(3):613-8. doi: 10.1007/BF00249804. Exp Brain Res. 1987. PMID: 2961587
-
Inhibition of N-methyl-D-aspartate- and kainic acid-induced neurotransmitter release by omega-conotoxin GVIA.Br J Pharmacol. 1989 Nov;98(3):767-72. doi: 10.1111/j.1476-5381.1989.tb14604.x. Br J Pharmacol. 1989. PMID: 2574063 Free PMC article.
-
Excitotoxicity of quinolinic acid: modulation by endogenous antagonists.Neurotox Res. 2000;2(2-3):139-55. doi: 10.1007/BF03033790. Neurotox Res. 2000. PMID: 16787837
-
Structural analogues of pyrroline 5-carboxylate specifically inhibit its uptake into cells.J Membr Biol. 1991 May;121(3):269-77. doi: 10.1007/BF01951560. J Membr Biol. 1991. PMID: 1865491